NEW YORK, NY--(Marketwire - May 27, 2009) -
Marketwire and ExL Pharma are proud to
announce their partnership for the 5th Annual
Public Relations and
Communications Summit, taking place at the Pfizer World Headquarters in
Manhattan on July 27-28, 2009. Marketwire is now the
official newswire of this leading
meeting for communications professionals in pharmaceutical, biotechnology
and medical device companies.
Featuring over forty-five
speakers from top industry companies, this event will provide
comprehensive presentations, panel discussions and opportunities for
dialogue around issues that are most relevant to product, corporate and
organizational communicators. Attendance is limited to 200 attendees due
to space limitations, so anyone interested in joining us is encouraged to
register now.
For full event details, please visit www.exlpharma.com/5thPR. When
registering, please use discount code: P228MW for a 5% discount of
registration prices.
ExL Pharma's Lindsay Slater, conference director of the event, says, "We
are receiving an overwhelming response to this event. With the outstanding
caliber of speakers and companies represented, seats are going fast.
Industry communicators are eager to hear from so many VPs from leading
pharmaceutical companies and are especially looking forward to the FDA
presentation. We are looking forward to an extremely productive and
interactive meeting."
This event will provide concrete strategies for a range of topics relevant
to PR professionals, including how to prepare for and anticipate change
within internal and external communications, as well as how to manage fears
and concerns in an uncertain economy.
"We are thrilled to be partnering with an organization of this caliber,"
said Marketwire Vice President Sylvie Harton. "And we look forward to
providing EXL Pharma's attendees and sponsors with the latest tools,
services and technologies to enhance the reach of their news and
information."
Now in its fifth year, the PR and Communications Summit has earned
tremendous accolades from past attendees:
"This conference was excellent. Top notch speakers and terrific networking
opportunities with industry colleagues." -- PR Director, SANOFI PASTEUR
"Great overview of what is current and relevant to US Pharma and biotech
and excellent speaking faculty." -- Vice President, Global Communications,
SERONO
Highlighted sessions include:
RESTORING PUBLIC TRUST
The Pharmaceutical Industry Saves Millions of Lives, but Can it Save
Itself?
-- Steve Lampert, Executive Director, Corporate Affairs, ASTRAZENECA
-- Richard Salem, Executive Director, Public Affairs, DAIICHI SANKYO
-- Tim Hunt, Vice President, Public Affairs, BIOGEN IDEC
-- David Krawitz, Executive Director, Global Reputation Management &
Product Communications, AMGEN
Building an Effective Relationship between the Pharmaceutical Industry and
FDA in the Changing Environment
-- Julie Zawisza, Director, Office of Communications, FDA CENTER FOR DRUG
EVALUATION AND RESEARCH
STRATEGIC PARTNERSHIPS
Partnering with Advocacy Groups and Associations to Communicate the Value
Of Your Products
-- Rachel Bloom-Baglin, Executive Director, Corporate Communications,
ASTRAZENECA
-- Stacey Beckhardt, Associate Director, Product Communications, CEPHALON
-- Erica Wishner, Director, Consumer Marketing, ACORDA THERAPEUTICS
RACE FOR THE STORY
The Increasing Dependence on Wire Services and the Evaporation of In-Depth,
Investigative Health Care Journalism
-- Panel Moderator: Christopher Loder, Head, US Media Relations, PFIZER
-- Panelists: Senior Journalists from BLOOMBERG, REUTERS, BNET and Others
About ExL Events
ExL Pharma, a division of ExL
Events, Inc., is an emerging international leader in developing innovative,
educational events that serve the healthcare community and allied
professionals. Behind our diverse conference portfolio, our experienced
team conducts extensive market research and targeted outreach. The results
translate into innovative, high-quality conference events
designed to exceed the dynamic informational needs of the healthcare
community. For more information visit www.exlpharma.com.
About Marketwire
The only fully integrated North America-based global newswire, Marketwire,
Inc. is a full-service partner to IR, PR and MarCom professionals seeking
top-tier press
release distribution, media management, multimedia and monitoring
solutions. Marketwire's customer-centric corporate philosophy focuses on
being the best by infusing every aspect of its business with the following
core attributes: precision, adaptability, innovation and simplicity.
Marketwire delivers its clients' news to the world's media and financial
communities, fulfilling disclosure requirements in North America in
compliance with the Securities and Exchange Commission (SEC) and the
Toronto Stock Exchange (TSX), and serving as Primary Information Provider
(PIP) with the UK's Financial Services Authority (FSA). With a reputation
for technology leadership, Marketwire offers innovative products and
services -- including Social Media, Search Engine Optimization, Dashboard
Mobile Financial, News Dashboard coverage reports, exclusive access to
networks such as the Canadian Press Wire Network, Easy IR and Easy PR
workflow solutions, and more -- that help communication professionals
maximize their effectiveness while ensuring accuracy and best practices.
Having merged companies (Market Wire and CCNMatthews) in April 2006, and
enjoying a combined history of 25 years of service, Marketwire is now
majority-owned by OMERS Capital Partners, the private equity arm of one of
Canada's largest pension funds.
Marketwire distributes the majority of press releases issued by publicly
traded companies in Canada and serves more than 8,000 clients worldwide
through 20 offices on four continents. For more information, visit us at
http://www.marketwire.com/.
